{"doc_id": "si-2020-0241-reg-1", "parent_doc_id": "si-2020-0241", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 241 of 2020", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2020, "heading": "1. (1) These Regulations may be cited as the Medicinal Products", "text_raw": "1. (1) These Regulations may be cited as the Medicinal Products \n\n(Prescription and Control of Supply) (Amendment) (No. 4) Regulations 2020. \n\n(2) The citation “the Medicinal Products (Prescription and Control of \n\nSupply) Regulations 2003 to 2020” includes these Regulations.", "text_norm": "1 (1) regulation may cited medicinal product (prescription control supply) (amendment) (no 4) regulation 2020 (2) citation medicinal product (prescription control supply) regulation 2003 2020 includes regulation", "start_char": 642, "end_char": 921, "source_path": "downloads\\2020\\2020_0240.pdf", "extraction_method": "pdfminer", "checksum": "sha256:ae47aec52d077ea911b8b57c8546dc0b5fbf4d97b217ba58ea212698a012cb5a", "cross_refs": []}
{"doc_id": "si-2020-0241-reg-2", "parent_doc_id": "si-2020-0241", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 241 of 2020", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2020, "heading": "The Eighth Schedule (as amended by Regulation 5 of the Medicinal", "text_raw": "2. \n\nThe Eighth Schedule (as amended by Regulation 5 of the Medicinal \nProducts (Prescription and Control of Supply) (Amendment) Regulations 2018 \n(S.I. No. 530 of 2018)) to the Medicinal Products (Prescription and Control of \nSupply) Regulations 2003 (S.I. No. 540 of 2003) is amended by inserting after \nthe entry for “Influenza vaccine of a composition that has been approved for \nuse in the European Union for the season in question” the following entry: \n\nInfluenza \nvaccine \nnasal spray, \nsuspension \n\nBy intranasal \nadministration \nonly \n\nPrevention \nof seasonal \ninfluenza \n\n“ \n\nInfluenza \nvaccine (live \nattenuated) \nnasal spray \nsuspension \n\nof a \ncomposition \nthat has been \napproved for \nuse in the \nEuropean \nUnion for the \nseason in \nquestion \n\nChildren and \nadolescents \nfrom 24 \nmonths:", "text_norm": "2 eighth schedule (as amended regulation 5 medicinal product (prescription control supply) (amendment) regulation 2018 (s.i no 530 2018)) medicinal product (prescription control supply) regulation 2003 (s.i no 540 2003) amended inserting entry influenza vaccine composition approved use european union season question following entry influenza vaccine nasal spray suspension intranasal administration prevention seasonal influenza influenza vaccine (live attenuated) nasal spray suspension composition approved use european union season question child adolescent 24 month", "start_char": 921, "end_char": 1726, "source_path": "downloads\\2020\\2020_0240.pdf", "extraction_method": "pdfminer", "checksum": "sha256:ae47aec52d077ea911b8b57c8546dc0b5fbf4d97b217ba58ea212698a012cb5a", "cross_refs": []}
{"doc_id": "si-2020-0241-reg-0", "parent_doc_id": "si-2020-0241", "section_id": "reg-0", "section_label": "Regulation 0.", "si_number": "S.I. No. 241 of 2020", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2020, "heading": "(administered", "text_raw": "0.2 ml \n(administered \nas 0.1 ml per \nnostril) in \naccordance \nwith the \nsummary of \nproduct \ncharacteristics \nof the product \nadministered \nand \nImmunisation \nGuidelines for \nIreland, as \npublished and \nupdated by the \n\nNotice of the making of this Statutory Instrument was published in \n“Iris Oifigiúil” of 10th July, 2020. \n\n \n \n \n \n \n \n \n \n \n\f[241] 3 \n\nNational \nImmunisation \nAdvisory \nCommittee of \nthe Royal \nCollege of \nPhysicians of \nIreland. \n\n”. \n\nGIVEN under the Official Seal, \n\n3 July, 2020. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\f4 [241]", "text_norm": "0.2 ml (administered 0.1 ml per nostril) accordance summary product characteristic product administered immunisation guideline ireland published updated notice making statutory instrument published iris oifigiuil 10th july 2020 241 3 national immunisation advisory committee royal college physician ireland  given official seal 3 july 2020 stephen donnelly minister health 4 241", "start_char": 1726, "end_char": 2319, "source_path": "downloads\\2020\\2020_0240.pdf", "extraction_method": "pdfminer", "checksum": "sha256:ae47aec52d077ea911b8b57c8546dc0b5fbf4d97b217ba58ea212698a012cb5a", "cross_refs": []}
{"doc_id": "si-2020-0241-explanatory-note", "parent_doc_id": "si-2020-0241", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 241 of 2020", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2020, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations amend the Medicinal Products (Prescription and Control of \nSupply) Regulations 2003. \n\nThe purpose of these Regulations is to amend the Eighth Schedule to insert an \nentry for Intranasal Influenza Vaccination. \n\nThese Regulations may be cited as the Medicinal Products (Prescription and \nControl of Supply) (Amendment) (No. 4) Regulations 2020. \n\n \n \n \n \n \n \n \n\f[241] 5 \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \n52 FAICHE STIABHNA, BAILE ÁTHA CLIATH 2, \nD02 DR67. \n\nTeil: 076 110 6834 \nr-post: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \n52 ST. STEPHEN'S GREEN, DUBLIN 2, \nD02 DR67. \n\nTel: 076 110 6834 \nE-mail: publications@opw.ie \n—————— \n\n€ 3.00 \n\n(DH-85) 75. 07/20. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation amend medicinal product (prescription control supply) regulation 2003 purpose regulation amend eighth schedule insert entry intranasal influenza vaccination regulation may cited medicinal product (prescription control supply) (amendment) (no 4) regulation 2020 241 5 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais 52 faiche stiabhna baile atha cliath 2 d02 dr67 teil 076 110 6834 r-post publication opw.ie ------------ dublin published stationery office purchased government publication 52 st stephen green dublin 2 d02 dr67 tel 076 110 6834 e-mail publication opw.ie ------------ eur 3.00 (dh-85) 75 07 20 propylon", "start_char": 2319, "end_char": 3273, "source_path": "downloads\\2020\\2020_0240.pdf", "extraction_method": "pdfminer", "checksum": "sha256:ae47aec52d077ea911b8b57c8546dc0b5fbf4d97b217ba58ea212698a012cb5a", "cross_refs": []}
